Purchase Order 75N95019P00641
Award Date 9/16/19
Potential Completion Date 10/31/19
Potential Value $114K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53711, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,294.20 firm fixed price purchase order to Promega Corporation for CASPASE-GLO(R) 3/7 ASSAY, 100ML. The contract has a completion date of September 8, 2023 and was awarded on August 18, 2023. This order is not associated with a set-aside program. Promega Corporation is a global life sciences company that provides various biological research and diagnostic...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) Call to Promega Corporation for the CASPASE-GLO(R) 3/7 ASSAY. The potential value of the contract is $22,486.80 and the period of performance runs through March 8, 2024. Promega Corporation is a global life sciences company that provides DNA analysis equipment, reagents, assays, and related laboratory supplies...
- This is a firm-fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Promega Corporation for 100,000 units of the ADP-GLO Kinase Assay (Promega Product #V9103) with a potential value of $17,990.25. The contract has a performance period running through September 30, 2024. Promega is a global life sciences company that provides DNA analysis equipment, reagents, assays, and...
- This federal contract award, valued at $3,451.95, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Promega Corporation, a global life sciences company headquartered in Madison, Wisconsin. The award is for the purchase of CellTiter-Glo Luminescent Cell Viability Assay reagents, which are used for biological research, molecular diagnostics, and forensic analysis. Promega has supplied a range of specialized laboratory...
- This is a $39,209 firm-fixed-price purchase order awarded to Promega Corporation, a large for-profit manufacturer of laboratory equipment and reagents, by the National Institute on Drug Abuse (NIDA), a civilian agency. The contract is not set-aside and has an ultimate completion date of September 29, 2026. Promega has multiple indefinite delivery vehicles (IDVs) with NIH, FBI, and the Defense Health Agency to provide specialized laboratory products like DNA analysis systems and forensic reagents...
- This federal contract award is to Promega Corporation, a global life sciences company that develops, manufactures, and markets integrated systems and reagents used for biological research and molecular diagnostics. The $186,036 firm fixed-price purchase order was issued by the National Institute on Drug Abuse, part of the Department of Health and Human Services' National Institutes of Health. The contract, which does not have a set-aside designation, is for the delivery of DNA analysis...
- This firm-fixed-price purchase order was awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS) within the Department of Health and Human Services' National Institutes of Health. The $121,492.50 contract is for the procurement of detection assay systems with an August 2021 completion date. Promega has previously been awarded prime and subcontracts by various agencies including the NIH, CDC, DoD, and FBI to provide DNA...
- This federal contract award to Promega Corporation, a global life sciences company, has a ceiling value of $83,617.40. The contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency that is part of the National Institutes of Health (NIH). The contract is a Firm Fixed Price Purchase Order, with an ultimate completion date of September 3, 2018. It does not have a set-aside designation. Promega, as the prime contractor, will provide a range of specialized laboratory...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed price purchase order contract to Promega Corporation, a global life sciences company, for the provision of reagent kits and assays. The contract has a potential value of $22,784.00 and a completion date of July 21, 2020. Promega has previously provided DNA analysis equipment, reagents, assays, and related laboratory supplies to federal agencies...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation, a global life sciences company based in Madison, Wisconsin. The contract, valued at $79,736.40, is for the delivery of a LUCIFERASE 1000 ASSAY (AMBIS #1676428) product from Promega. This award does not utilize any set-aside designation. Promega is a major supplier of specialized laboratory equipment,...